KRYS News and Press, Krystal Biotech Inc. From 04/15/20

Shares of Krystal Biotech (KRYS) have risen by over 200% since my July 2018 article recommended readers accumulate shares based on optimism for the gene therapy pioneer's STAR-D platform and its potential to address multiple rare skin diseases. On the other hand, performance is only slightly...

RenovaCare ( OTCPK:RCAR +0.8% ) announces that its SkinGun , a patented device for spraying self-donated stem cells for the regeneration of skin and other organs/tissues, is being used in a preclinical study at King's College London to apply gene-supplemented cells (gene therapy) for ac...

Allakos (NASDAQ: ALLK ) initiated with Underperform rating and $34 (42% downside risk) price target at SMBC Nikko. More news on: Allakos Inc., Avadel Pharmaceuticals plc, Krystal Biotech, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Krystal Biotech (NASDAQ: KRYS ): FY GAAP EPS of -$1.20 beats by $0.01 . Cash, cash equivalents and short-term investments of $193.7M Shares  +1.8% Press Release More news on: Krystal Biotech, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news,

Phase 3 trial of B-VEC (Beremagene Geperpavec, previously “KB103”) to treat dystrophic epidermolysis bullosa (“DEB”) to start in 1H 2020 Interim results on Phase 1/2 clinical study on KB105 to be announced in 1H 2020 Planned filing of two Investigational...

PITTSBURGH, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced the appointment of Kathryn Romano...

PITTSBURGH, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced that Krish S. Krishnan, chairman a...

Krystal Biotech (NASDAQ: KRYS ) announces the ground breaking of the second commercial gene therapy facility in Findlay Township, Pennsylvania. More news on: Krystal Biotech, Inc., Healthcare stocks news, Read more ...

PITTSBURGH, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS), a gene therapy company developing medicines to treat rare diseases, announced today the ground breaking of the second commercial gene therapy facility in Findlay Township, Pennsylvania. The Findlay-based ...

PITTSBURGH, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS), a gene therapy company developing medicines to treat rare diseases, today announced the appointment of Jennifer Chien to the newly created position of chief commercial officer, effective Ja...